The only FDA approved radioactive antibody that can be used for treatment of lymphoma:
Ibritumomab is a TNF a inhibitor is a newly approved drug by the FDA for treating both Hodgkin and non-Hodgkin lymphomas. It is a monoclonal antibody radioimmunotherapy treatment for relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma, a lymphoproliferative disorder. Other given drugs are also TNF a inhibitors mostly used in rheumatoid ahritis, ankylosing spondylosis, chron's disease, etc REF KD tripathi 8th ed
Trastuzumab
Ibritumomab
Rituximab
Imatinib
Immunomodulators